|BioShares Biotechnology Clinical Trials -- USA Etf|| |
USD 30.6 0.75 2.51%
Considering 30-days investment horizon, and your above average risk tolerance our recommendation regarding BioShares Biotechnology Clinical Trials is 'Sell'
For the selected time horizon BioShares Biotechnology Clinical Trials has a mean deviation of 1.26, semi deviation of 1.23, standard deviation of 1.67, variance of 2.79, downside variance of 3.47 and semi variance of 1.5
Macroaxis buy, hold, or sell suggestion module can be used to complement BioShares Biotechnology buy, hold, or sell recommendation provided by average analyst sentiment
. It analyzes the etf potential to grow using fundamental, technical, data market data available at the time. Please makes use of BioShares Biotechnology Number of Employees
as well as the relationship
between One Year Return
and Net Asset
to make buy, hold, or sell decision on BioShares Biotechnology.
Returns Distribution Density
|Mean Return||0.54||Value At Risk||2.01|
|Potential Upside||2.79||Standard Deviation||1.67|
BioShares Biotechnology Greeks
BioShares Biotechnology Volatility Alert
BioShares Biotechnology Clinical Trials has relatively low volatility with skewness of -0.55 and kurtosis of 0.34. However, we advise all investors to independently investigate BioShares Biotechnology Clinical Trials to ensure market all accessible information is consistent with the expectations about its upside potential and future risk-adjusted return.